Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03016975Terminated
Randomised, open-label trial in heart failure (HF) (3 arms), sponsored by Edwards Lifesciences. Primary endpoints: Prevalence of MR ≤ 2+ and Hierarchical Comparison of Randomized Device and Randomized Control Groups at 1 year and Number of Participants With Major Adverse Events at 30 days. Started Jun 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03016975.